Partner Brent Babcock Quoted in WSJ Article on CRISPR Patent Ruling

Partner Brent Babcock, Chair of the firm’s USPTO Trials & Post-Grant Proceedings group, was quoted in “Patent Ruling for Crispr Gene Editing Favors the Broad Institute,” an article published in The Wall Street Journal.

Read the full article here >> (Subscripton required)